<DOC>
	<DOCNO>NCT00918775</DOCNO>
	<brief_summary>The goal clinical research study learn surgical removal primary tumor part cancer spread part body good method treat patient kidney cancer . Only part cancer spread remove surgery .</brief_summary>
	<brief_title>Metastasectomy Study Renal Cell Carcinoma ( RCC )</brief_title>
	<detailed_description>This research study design follow progress surgery complete . You receive drug treatment part research study . You may however receive non-study treatment surgery . Study Visits : Every 6 month 5 year surgery , follow test procedure perform : - You physical exam , include measurement weight vital sign . - Your performance status record . - Blood ( 2-3 teaspoon ) urine collect routine test . - You CT scan MRI scan chest , stomach area , brain check status disease . - If study doctor think necessary , bone scan check status disease . Length Study : You study visit 5 year surgery complete . You take study early disease get bad , study doctor think longer best interest continue . Long-Term Follow-Up : About every 6 month last study visit , study staff either review medical record contact phone email collect information health , see , anti-cancer treatment may receive . If contact phone , call last 5 minute time . This investigational study . Up 120 patient take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<criteria>1 . Patients histologically cytologically confirm renal cell carcinoma ( RCC ) . 2 . 2 . Patients clinical reason undergo surgical resection tumor . There two main category patient : ) Patients fully resectable disease define lesion accessible surgeon two separate surgical session , expect render surgically evidence disease ( NED ) . b ) Patients undergo noncurative procedure relief symptom management threaten lesion . 3 . Patients deem resectable subspecialty surgeon involve patient 's care 4 . Patients must give write informed consent prior initiation therapy , keep policy institution . Patients history major psychiatric illness must judge able fully understand investigational nature study risk associate therapy . The approved consent attach protocol 5 . Patients must ability comply study and/or followup procedure . 6 . Both men woman member race ethnic group eligible trial . 1 . Patients must active acute infection could worsen surgery interfere study . 2 . Patients must clinically significant cardiovascular disease , peripheral vascular disease create unacceptably high operative risk . 3 . Patients must history disease , metabolic dysfunction , physical examination finding , clinical laboratory find give reasonable suspicion disease condition contraindicate surgical resection , render subject high risk treatment complication . 4 . Patients must history uncontrolled severe depression .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Renal Cell Carcinoma</keyword>
	<keyword>RCC</keyword>
	<keyword>Kidney</keyword>
	<keyword>Metastasectomy</keyword>
	<keyword>Surgery</keyword>
	<keyword>Tumor Removal</keyword>
</DOC>